Assessment of IgH PCR strategies in multiple myeloma

Journal of Clinical Pathology

Volumn 49, Issue 8, 1996, Pages 672-675

  Owen, R G ^a   Johnson, R J ^a   Rawstron, A C ^a   Evans, P A ^a   Jack, A ^a   Smith, G M ^a   Child, J A ^a   Morgan, G J ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Immunoglobulin heavy chain gene; Myeloma; PCR

Indexed keywords

ARTICLE; BONE MARROW; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0029789226     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.8.672     Document Type: Article

References (28)

1. Brisco MJ, Tan LW, Orsborn AM, Morley AA. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol 1990;75:163-7.
2. Deanne M, Norton JD. Immunoglobulin gene "fingerprinting": an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. Br J Haematol 1991; 77:274-81.
3. Ramasamy I, Brisco M, Morley A. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. J Clin Pathol 1992;45:770-5.
4. Diss TC, Peng H, Wotherspoon AC, Isaacson PG, Pan L. Detection of monoclonality in low grade B-cell lymphomas using the polymerase chain is dependent on primer selection and lymphoma type. J Pathol 1993;169:291-5.
5. Aubin J, Davi F, Nguyen-Salomon F, Leboeuf D, Debert C, Taher M, et al. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 1995;9:471-9.
6. Deanne MD, Norton JD. Immunoglobulin heavy chain variable region family usage is independent of tumour cell phenotype in human B lineage leukemias. Eur J Immunol 1990;20:2209-17.
7. Trainor KJ, Brisco MJ, Wan JH, Neoh S, Grist S, Morley AA. Gene rearrangements in B and T lymphoproliferative disease detected by the polymerase chain reaction. Blood 1991;78:192-8.
8. Mayer R, Logtenberg T, Strauchen J, Dimitriu-Bona A, Mayer L, Mechanic S, et al. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Blood 1990;75:1518-24.
9. Kipps TJ, Carson DA. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune disorders. Blood 1993;81:2475-87.
10. Ralph QM, Brisco MJ, Joshua DE, Brown R, Gibson J, Morley AA. Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain gene. Blood 1993;82:202-6.
11. Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, et al. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992;80:1818-24.
12. Corradini P, Voena C, Omede P, Astolfi M, Boccadoro M, Dalla-Favera R, et al Detection of circulating tumour cells in multiple myeloma by a PCR based method. Leukemia 1993;11:1879-82.
13. Bird JM, Bloxham D, Samson D, Marcus RE, Russell NH, Kelsey SM, et al. Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. Br J Haematol 1994;88:110-16.
14. Owen RG, Haynes AP, Evans PA, Johnson RJ, Rawstron A, McQuaker G, et al. Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD 34 positive selection. J Clin Pathol: Mol Pathol 1996;49:M112-17.
15. Schiller G, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M, et al Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995;86:390-7.
16. Gazitt Y, Reading CC, Huffman R, Wickrema A, Vesole DH, Jaganath S, et al. Purified CD34+Lin-Thy+stem cells do not contain clonal myeloma cells. Blood 1995;86:381 9.
17. Bird JM, Russell NH, Samson D. Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long term survivors. Bone Marrow Transplant 1993;12:651-4.
18. Corradini P, Voena C, Astolfi M, Ladetto M, Tarella C, Boccadoro M, et al. High dose sequential chemoradiotherapy in multiple myeloma: residual tumour cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 1995;85:1596-602.
19. Baker BW, Deanne M, Gilleece MH, Johnston D, Scarffe JH, Norton JD. Distinctive features of immunoglobulin heavy chain variable region gene rearrangement in multiple myeloma. Leuk Lymphoma 1994;14:291-301.
20. Bakkus MHC, Heirman C, Van Riet I, Van Camp B, Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 1992;80:2326-35.
21. Berenson JR, Vescio RA, Hong CH, Cao J, Kim A, Lee CC, et al. Multiple myeloma clones are derived from a cell in late B cell development. Curr Top Microbiol Immunol 1994; 194:25-33.
22. Vescio RA, Kieber-Emmons T, Lee JC, Wu CH, Cao J, Shin J, et al. Immmunoglobulin heavy chain gene analysis proves that myeloma oncogenesis occurs late in B-cell development. Proceedings of the Vth International Workshop on Multiple Myeloma. Section 3. 1995:19.
23. Wagner SD, Martinelli V, Luzzatto L. Similar patterns of Vk gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia and myeloma. Blood 1994; 83:3647-53.
24. Bahler DW, Campbell MJ, Hart S, Miller RA, Levy S, Levy R. Ig VH gene expression among human follicular lymphoma. Blood 1991;78:1561-8.
25. Deanne M, Norton JD. Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B-lineage leukaemias. Leukemia 1991;5:646-50.
26. Deanne M, Baker BW, Norton JD. Immunoglobulin VH4 gene usage in B lymphoid leukaemias. Br J Haematol 1993;84:242-9.
27. Maloum K, Magnac C, Pritsch O, Binet JL, Merle-Beral H, Dighiero G. Skewed rearrangement of the VH4-21 gene during pre-B acute lymphoblastic leukemia. Leuk Lymphoma 1995;17:435-41.
28. Rettig MB, Vescio RA, Cao J, Wu CH, Lee JC, Han E, et al. VH gene usage in multiple myeloma: complete absence of VH4-21 (VH4-34) gene [abstract]. Blood 1995;86(Suppl 1):60a.